Log in to save to my catalogue

Inhibition of VEGF‐dependent angiogenesis and tumor angiogenesis by an optimized antibody targeting...

Inhibition of VEGF‐dependent angiogenesis and tumor angiogenesis by an optimized antibody targeting...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_29cd0caafe6040fc935cb8e939eb8841

Inhibition of VEGF‐dependent angiogenesis and tumor angiogenesis by an optimized antibody targeting CLEC14a

About this item

Full title

Inhibition of VEGF‐dependent angiogenesis and tumor angiogenesis by an optimized antibody targeting CLEC14a

Publisher

United States: John Wiley & Sons, Inc

Journal title

Molecular oncology, 2018-03, Vol.12 (3), p.356-372

Language

English

Formats

Publication information

Publisher

United States: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

The C‐type lectin‐like domain of CLEC14a (CLEC14a‐C‐type lectin‐like domain [CTLD]) is a key domain that mediates endothelial cell–cell contacts in angiogenesis. However, the role of CLEC14a‐CTLD in pathological angiogenesis has not yet been clearly elucidated. In this study, through complementarity‐determining region grafting, consecutive deglycos...

Alternative Titles

Full title

Inhibition of VEGF‐dependent angiogenesis and tumor angiogenesis by an optimized antibody targeting CLEC14a

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_29cd0caafe6040fc935cb8e939eb8841

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_29cd0caafe6040fc935cb8e939eb8841

Other Identifiers

ISSN

1574-7891

E-ISSN

1878-0261

DOI

10.1002/1878-0261.12169

How to access this item